Press release
United States Arteriovenous Fistula Market Size and Share Analysis with Emerging Technologies 2026
Arteriovenous Fistula Market Size
DataM Intelligence unveils its latest report on the "Arteriovenous Fistula Market Size 2025," offering an in-depth analysis of market trends, growth drivers, competitive landscape, and regional dynamics. The study covers market size in value and volume, CAGR forecasts, and emerging opportunities that can guide businesses in seizing growth potential and crafting winning strategies. Packed with data-driven insights on current developments and future trends, this report is essential for companies aiming to stay ahead in the competitive Market.
Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://datamintelligence.com/download-sample/arteriovenous-fistula-market?kb
United States: Recent Industry Developments
✅ December 2025: A leading vascular access device manufacturer announced new AV fistula creation systems designed to streamline procedures and reduce operative times for dialysis patients.
✅ November 2025: Clinical centers across the U.S. reported improved long‐term patency outcomes with integrated imaging technologies during AV fistula planning and placement.
✅ October 2025: Healthcare providers increased training programs for interventional nephrologists and surgeons to enhance AV fistula success rates and reduce reliance on catheters.
Japan: Recent Industry Developments
✅ December 2025: Japanese medical device firms unveiled minimally invasive AV fistula formation tools to improve patient comfort and recovery.
✅ November 2025: Collaboration between hospitals and research centers accelerated evaluation of new techniques aimed at reducing AV fistula maturation failure.
✅ October 2025: Increased adoption of ultrasound‐guided AV fistula creation protocols demonstrated improved patient outcomes in dialysis clinics.
List of Top Key Player:
Pervasis Therapeutics, Inc., Proteon Therapeutics, Inc., Medtronic, Cook Medical, Fresenius Medical Care AG & Co. KGaA, Poly Medicure Limited, Becton Dickinson and Company, Braun Melsungen Ag, Teleflex Incorporated
Forecast Projection:
The Global Arteriovenous Fistula Market is poised for significant growth between 2025 and 2032. In 2024, the market maintained a steady upward trajectory, and with strategic initiatives by leading players accelerating adoption, the market is expected to soar throughout the forecast period. Companies leveraging these trends are well-positioned to capture emerging opportunities and maximize revenue potential.
Latest FDA
1. Amplifi Vascular received FDA IDE approval in October 2025 for AMPLIFI-1 pivotal trial of its Vein Dilation System to improve AVF maturation.
2. Venova Medical gained FDA IDE approval in August 2025 for VENOS-3 pivotal study of Velocity percutaneous AVF system; first patients enrolled November 2025.
3. Laminate Medical's VasQ extravascular support received FDA De Novo approval (September 2023) and Breakthrough Device Designation (June 2020)
Market Intelligence Research Process:
The Arteriovenous Fistula Market research report by DataM Intelligence combines primary and secondary data to deliver deep, actionable insights. It examines the full spectrum of factors shaping the industry, from government regulations and market conditions to competitive dynamics, historical trends, technological breakthroughs, upcoming innovations, and potential challenges. This comprehensive analysis not only highlights growth prospects but also identifies barriers, equipping businesses to navigate market volatility and capitalize on emerging opportunities.
Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=arteriovenous-fistula-market?kb
Key Segmentation:
By Type: Radial Cephalic fistula, Brachial Cephalic, Brachial Basilic Transposition
By Treatment Methods: Endovascular embolization, Microsurgery, Stereotactic radiosurgery
Growth Regional Analysis:
| Europe | 30% |
Robust dialysis programs and advanced vascular access technologies support market growth.
| Asia-Pacific | 20% |
Growing patient population and improving healthcare access fuel market expansion.
| Middle East & Africa | 6% |
Emerging healthcare infrastructure and increasing awareness contribute to gradual growth.
| South America | 4% |
Limited resources and healthcare disparities restrain market penetration but show potential.
Benefits of the Report:
Chapter 1 - Market Overview: Kickstarts the report with a comprehensive snapshot of the Arteriovenous Fistula Market, summarizing key segments by region, product type, and application. Highlights include market size, segment growth potential, and short- & long-term industry outlook.
Chapter 2 - Emerging Trends: Uncovers the game-changing trends and high-impact innovations shaping the future of the industry.
Chapter 3 - Competitive Landscape: Offers a deep dive into market competition, detailing revenue shares, strategic initiatives, and recent mergers & acquisitions.
Chapter 4 - Top Player Profiles: Features detailed company profiles, covering revenue, profit margins, product lines, and major milestones for leading market players.
Chapters 5 & 6 - Regional & Country Analysis: Breaks down revenue performance across global regions, providing insights on market sizes, opportunities, and growth prospects worldwide.
Chapter 7 - Segmentation Analysis: Explores market segmentation by type, revealing high-potential categories and guiding businesses towards lucrative areas.
Chapter 8 - Application Insights: Examines downstream markets and identifies promising sectors for expansion, showing how different applications are driving growth.
Chapter 9 - Supply Chain Mapping: Maps the entire industry supply chain, highlighting upstream and downstream activities for a holistic market perspective.
Chapter 10 - Key Takeaways: Concludes with critical insights and actionable strategies, equipping stakeholders to make informed decisions and stay ahead in the market.
Get Customization in the report as per your requirements: https://datamintelligence.com/customize/arteriovenous-fistula-market?kb
Reimbursement
✦ CMS granted Laminate Medical's VasQ Transitional Pass-Through (TPT) payment under code C8000 effective October 1, 2024, providing incremental Medicare reimbursement for AVF creation with the device alongside standard fistula payments.
✦ Favorable policies support AVF as preferred hemodialysis access, though evidence gaps for new devices may limit broad coverage.
Request 2 Days Free Trials with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription?kb
Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.
✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring
Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release United States Arteriovenous Fistula Market Size and Share Analysis with Emerging Technologies 2026 here
News-ID: 4340126 • Views: …
More Releases from DataM Intelligence 4 Market Research LLP
Diagnostic Electrophysiology Catheters Market to Grow at 8.1% CAGR through 2031, …
According to DataM Intelligence, the global Diagnostic Electrophysiology Catheters market reached US$ 1.6 billion in 2022 and is expected to reach US$ 2.9 billion by 2031, growing at a CAGR of 8.1% during the forecast period 2024-2031. This growth is propelled by the increasing incidence of cardiac arrhythmias such as atrial fibrillation, growing adoption of minimally invasive electrophysiology procedures, advancements in high-density mapping and ablation technologies, rising geriatric population prone…
Wi-Fi Analytics Market Report 2026: Key Players, Innovations & Demand Drivers
Wi-Fi Analytics Market is expected to grow at a CAGR of 23.7% during the forecast period (2024-2031).
DataM Intelligence unveils its latest report on the "Wi-Fi Analytics Market Size 2025," offering an in-depth analysis of market trends, growth drivers, competitive landscape, and regional dynamics. The study covers market size in value and volume, CAGR forecasts, and emerging opportunities that can guide businesses in seizing growth potential and crafting winning strategies.…
Asthma Drugs Market Expected to Reach US$ 37.62 Billion by 2032, Growing at a CA …
The Global Asthma Drugs Market reached US$ 25.72 billion in 2024 and is expected to reach US$ 37.62 billion by 2032, growing at a CAGR of 5.2% during the forecast period 2025-2032. Market growth is driven by the high global prevalence of asthma, rising environmental pollution, increasing awareness of early diagnosis and treatment, and the growing availability of advanced therapeutic options. Asthma remains a major public health concern, frequently leading…
Nanofilms Market Set for Strong Growth to USD 7.73 Billion by 2032, Led by North …
The global nanofilms market, valued at USD 2.87 billion in 2024, is projected to reach USD 7.73 billion by 2032, growing at a CAGR of 13.19% during 2025-2032.
Market growth is driven by surging demand in electronics for thin-film coatings, expanding applications in healthcare for drug delivery and sensors, and rising needs in renewable energy for solar cells and batteries. Advancements in deposition technologies like atomic layer deposition (ALD), growing investments…
More Releases for Arteriovenous
Arteriovenous Fistula Market Trends, Innovations, and Growth Opportunities
Arteriovenous fistulas (AVFs) are considered the gold standard for vascular access in patients requiring hemodialysis. As chronic kidney disease (CKD) prevalence rises globally, the demand for effective, long-lasting vascular access solutions has intensified. AVFs offer improved blood flow, reduced risk of infection, and superior long-term outcomes compared to other access types such as grafts or catheters. This market is witnessing steady growth, fueled by increasing CKD incidence, aging populations, and…
Arteriovenous Fistula Market Size, Share, Industry, Forecast and outlook (2023-2 …
A new Report by DataM Intelligence, titled "Arteriovenous Fistula Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2031,"" offers a comprehensive analysis of the industry, which comprises insights on the Arteriovenous Fistula market analysis. The report also includes competitor and regional analysis, and contemporary advancements in the market.
This report has a complete table of contents, figures, tables, and charts, as well as insightful analysis. The Arteriovenous Fistula market has…
Arteriovenous Malformations Market to Witness Growth by 2032, Estimates DelveIns …
DelveInsight's "Arteriovenous Malformations Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Arteriovenous Malformations (AVM), historical and forecasted epidemiology as well as the Arteriovenous Malformations (AVM) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan.
The Arteriovenous Malformations (AVM) market report provides current treatment practices, emerging drugs, the market share of the individual therapies, and the current and forecasted Arteriovenous…
Global Arteriovenous Fistula Treatment Market Status and Outlook (2020-2025)
Global Info Research offers a latest published report on Arteriovenous Fistula Treatment Analysis and Forecast 2020-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key global Arteriovenous Fistula Treatment Concentrate players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
Click to view the full report TOC, figure…
Arteriovenous Fistula Needle Market 2016-2024 Industry Size, Shares, Research Tr …
AV fistula needle is a connection of artery to vein. The arteriovenous fistula needle is recommended as the first choice for hemodialysis. Arteriovenous fistula needles are used in conjunction with a connector of hemodialysis blood tubing set. These needles connect blood lines to the blood vessel through during dialysis procedure via an internal fistula. Health care providers recommend an arteriovenous fistula needle due to its good blood flow for dialysis,…
Arteriovenous (Av) Fistula Needle Market - Global Industry Analysis 2024
AV fistula needle is a connection of artery to vein. The arteriovenous fistula needle is recommended as the first choice for hemodialysis. Arteriovenous fistula needles are used in conjunction with a connector of hemodialysis blood tubing set. These needles connect blood lines to the blood vessel through during dialysis procedure via an internal fistula.
Health care providers recommend an arteriovenous fistula needle due to its good blood flow for dialysis,…
